TGRX-678 Pharmacokinetic Mass Balance

Clinical trial NCT06986772 · COMPLETED

Trial details

NCT number: NCT06986772
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2025-07-07
Primary completion: 2025-08-17
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.